Utama › Sindrom Bronkiolitis Obliterans › North Carolina
Kajian klinikal Sindrom Bronkiolitis Obliterans di North Carolina
7 kajian untuk Sindrom Bronkiolitis Obliterans sedang mencari peserta di lokasi di North Carolina.
Bandar di North Carolina
Teks kajian rasmi (Bahasa Inggeris)
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Duke Eye Center - Ophthalmology, Durham
Mengambil pesertaFasa 3
Umur 10 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Levine Cancer Institute, Charlotte
- Duke Cancer Center, Durham
Mengambil pesertaFasa 2
Umur 2 hingga 17 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Wake Forest Baptist Medical Center, Winston-Salem
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05919511A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06615050Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Duke, Durham
Mengambil pesertaFasa 1
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Jan 2026 · NCT06233110A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Levine Cancer Institute, Charlotte
- Duke University Hospital, Durham
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.